The Finnish Research Impact Foundation awarded Professor Riitta Lahesmaa €224,639 in funding
The Finnish Research Impact Foundation awarded Professor Riitta Lahesmaa €224,639 in funding for a project that explores a treatment of cancer which utilizes body’s own immune defense system. Lahesmaa is the Director of the Turku Bioscience Center and InFLAMES flagship group leader. The research is conducted in cooperation with Orion Pharma.
Read the full article in Finnish
Recent Posts
- Researchers are investigating how snakes lost their limbsSnakes have not always been legless, but have lost their limbs through evolution. Professor Laura Read moreOctober 8, 2026
- Frontiers of Science seminars are starting this weekAutumn 2026 Frontiers of Science seminars start this week. Come for a coffee and sandwich Read moreOctober 5, 2026
- Dissertation Defence: Eleftheria MaranouMSc Eleftheria Maranou, from affiliated MIORG group, succesfully defended the dissertation in Immunology titled “The Achilles’ heel of Read moreSeptember 1, 2026
- Researchers discover molecular mechanism that helps aggressive colorectal cancer to spreadResearchers from the University of Turku in Finland, Turku Bioscience Centre and Gustave Roussy Institute Read moreAugust 25, 2026
- The Novo Nordisk Foundation has awarded funding of approximately one million euros to a research project led by Professor Jukka WestermarckThe Novo Nordisk Foundation has awarded funding of approximately one million euros to a research Read moreAugust 21, 2026
- The Jane and Aatos Erkko Foundation has granted nearly €1 million to support research led by Professor Jukka Westermarck993 000 € was granted to a research project led by our Group Leader Professor Jukka Read moreApril 2, 2026